10.2337/diabetes.53.1.5 60 HuE.-H.TsaiM.-L.LinY.ChouT.-S.ChenT.-H
Cost, Accessibility, and Insurance Coverage Access and affordability remain major challenges
Not always more, but it often explains real-world differences better than the label alone
Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways

Recommendations for the peri-operative management of patients taking glucagon-like peptide-1 receptor agonists and glucose-dependent insulinotropic peptide [1] : The risk of pulmonary aspiration and mitigation strategies should be discussed with the patient using a shared decision-making approach." "Patients should continue to take glucagon-like peptide-1 receptor agonists throughout the perioperative period." "Patients and clinicians should adhere to recommended fasting guidelines." "Upper gastrointestinal symptoms alone should not be used to determine gastric content." "Regional anaesthesia should be considered as the primary anaesthetic technique, if appropriate." "Point-of-care gastric ultrasound should be considered before induction of anaesthesia to facilitate risk stratification, if appropriate." "Individualised pulmonary aspiration risk assessment should be completed, accounting for drug, patient and procedural factors." "Anaesthesia and airway management should aim to reduce the risk of pulmonary aspiration on induction of anaesthesia, during maintenance and after emergence of anaesthesia

Unlike some interventions where you complete a course and maintain results independently, metabolic peptides typically require continued use to prevent regain